Erik Khan v. United States of America

District Court, D. New Jersey·Decided August 26, 2026·No. 3:24-cv-08976·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

ERIK KHAN,

Plaintiff, Civil Action No. 24-8976 (RK) (TJB) v. MEMORANDUM OPINION UNITED STATES OF AMERICA,

Defendant.

KIRSCH, District Judge

THIS MATTER comes before the Court upon the Motion for Dismiss for Lack of Jurisdiction and for Failure to State a Claim filed by Defendant United States of America (“Defendant”). (“Def. Mot.,” ECF No. 26.) Plaintiff Erik Khan (“Plaintiff”) filed an opposition brief, (“Pl. Opp.,” ECF No. 34), and Defendant replied, (“Def. Reply,” ECF No. 35). The Court has considered the parties’ submissions and resolves the matter without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1. For the reasons set forth below, Defendant’s Motion to Dismiss is GRANTED. I. BACKGROUND1 Plaintiff, proceeding pro se, pursues claims under the Federal Tort Claims Act (“FTCA”), 28 U.S.C. §§ 1346(b), 2671-2680, for negligence, negligent infliction of emotional distress, and negligent supervision and training in connection with the Federal Bureau of Prison’s (“BOP”) alleged failure to dispense Plaintiff’s prescribed medications in a timely manner. (“Compl.,” ECF

1 The facts set forth in this Memorandum Opinion are taken as true directly from the Complaint for the sole purpose of deciding Defendant’s pending Motion. See Phillips v. County of Allegheny, 515 F.3d 224, 228 (3d Cir. 2008). No. 1 ¶¶ 1, 19−39.) Plaintiff is currently incarcerated at the Federal Correctional Institution in Fort Dix, New Jersey (“FCI Fort Dix”). (Id. ¶ 4.) He alleges that he suffers from “several chronic health conditions, including obesity, sleep apnea, tachycardia, hypertension, hyperlipidemia, lower extremity arthritis, depression, and anxiety” with a “documented family history of major cardiac and/or stroke events.” (Id. ¶ 6.) Plaintiff asserts that to treat these conditions he is prescribed

“Metoprolol (also known as Lopressor), Atorvastatin (also known as Lipitor), Aspirin, Fluoxetine (also known as Prozac), and Losartan.” (Id. ¶ 7.) Plaintiff alleges that he is under the care of “Dr. Patel” at FCI Fort Dix and that Dr. Patel has consistently prescribed these medications since 2016. (Id. ¶ 9.) Plaintiff asserts that he requires these specific medications daily. (Id.) Plaintiff alleges that on August 26, 2022, BOP officials moved him to the Special Housing Unit (“SHU”). (Id. ¶ 10.) Plaintiff claims that upon arrival in the SHU, his medications were missing from his belongings. (Id. ¶ 11.) He asserts that, despite repeatedly informing BOP staff, he was “deprived” of his prescribed medications “on at least 21 separate occasions” between August 26, 2022, and October 7, 2022. (Id. ¶ 12.) He claims that the deprivation of his medication

was in violation of BOP’s own policies requiring the pharmacists at FCI Fort Dix to obtain a list of all inmates placed in the SHU during the previous 24 hours and to ensure that all restricted medications are available for distribution to these inmates during SHU rounds. (Id. ¶ 16.) Without his medication during the alleged periods, Plaintiff claims that he suffered “excessive heart rate . . . , elevated blood pressure, severe chest pain, headaches, weakness, and severe emotion distress including suicidal thoughts.” (Id. ¶ 13.) On October 5, 2022, in particular, Plaintiff asserts that he experienced “severe chest pain and weakness, believing he was having a heart attack.” (Id. ¶ 14.) He alleges that the attending physician attributed this condition directly to the deprivation of his medication. (Id.) Plaintiff also asserts that on October 7, 2022, due to his deteriorated mental state, “he drafted suicide notes and was placed on suicide watch.” (Id. ¶ 15.) Plaintiff filed the initial Complaint on September 5, 2024. (ECF No. 1.) On February 13, 2026, Defendant moved to dismiss. (ECF No. 26.) Plaintiff filed an opposition brief on May 6, 2026, and Defendant submitted a reply brief. (ECF Nos. 34−35.)

II. LEGAL STANDARD Under Federal Rule of Civil Procedure (“Rule”) 12(b)(1), a court must grant a motion to dismiss if it lacks subject matter jurisdiction to hear the claim. Fed. R. Civ. P. 12(b)(1). In evaluating a Rule 12(b)(1) motion to dismiss, courts must first determine whether the motion “presents a ‘facial’ attack or a ‘factual’ attack on the claim at issue, because that distinction determines how the pleading must be reviewed.” Const. Party of Pa. v. Aichele, 757 F.3d 347, 357 (3d Cir. 2014) (quoting In re Schering Plough Corp. Intron/Temodar Consumer Class Action, 678 F.3d 235, 243 (3d Cir. 2012)). “A facial 12(b)(1) challenge, which attacks the complaint on its face without contesting its alleged facts, is like a 12(b)(6) motion in requiring the court to consider the allegations of the complaint as true.” Hartig Drug Co. v. Senju Pharm. Co., 836 F.3d 261, 268

(3d Cir. 2016) (internal quotation marks omitted). A factual challenge, on the other hand, “attacks allegations underlying the assertion of jurisdiction in the complaint, and it allows the defendant to present competing facts.” Id. The “trial court is free to weigh the evidence and satisfy itself as to the existence of its power to hear the case” and “the plaintiff will have the burden of proof that jurisdiction does in fact exist.” Petruska v. Gannon Univ., 462 F.3d 294, 302 n.3 (3d Cir. 2006) (quoting Mortensen v. First Fed. Sav. & Loan Ass’n, 549 F.2d 884, 891 (3d Cir. 1977)). “Therefore, a 12(b)(1) factual challenge strips the plaintiff of the protections and factual deference provided under 12(b)(6) review.” Hartig Drug Co., 836 F.3d at 268. III. DISCUSSION Defendant challenges Plaintiff’s claims on several jurisdictional grounds: (1) the discretionary function exception to the FTCA bars Plaintiff’s negligent hiring and negligent supervision claim; (2) Plaintiff cannot pursue claims for negligence or negligent infliction of emotional distress under the FTCA because the duty of care invoked by Plaintiff arises under

Free access — add to your briefcase to read the full text and ask questions with AI

Erik Khan v. United States of America, (D.N.J. 2026).

Erik Khan v. United States of America (Erik Khan v. United States of America) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Muniz
374 U.S. 150 (Supreme Court, 1963)
United States v. Orleans
425 U.S. 807 (Supreme Court, 1976)
Federal Deposit Insurance v. Meyer
510 U.S. 471 (Supreme Court, 1994)
United States v. Larry Stuler
396 F. App'x 798 (Third Circuit, 2010)
Tracy v. Freshwater
623 F.3d 90 (Second Circuit, 2010)
Cna v. United States
535 F.3d 132 (Third Circuit, 2008)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Russo v. Nagel
817 A.2d 426 (New Jersey Superior Court App Division, 2003)
Charles Pratt v. New York & New Jersey Port Aut
563 F. App'x 132 (Third Circuit, 2014)
Constitution Party of Pennsylv v. Carol Aichele
757 F.3d 347 (Third Circuit, 2014)
Hollister v. United States Postal Service
142 F. App'x 576 (Third Circuit, 2005)
Ginamarie Gomes v. the County of Monmouth and Correct
134 A.3d 33 (New Jersey Superior Court App Division, 2016)
Hartig Drug Co Inc v. Senju Pharmaceutical Co Ltd
836 F.3d 261 (Third Circuit, 2016)
Coulter v. Paul Laurence Dunbar Community Center
685 F. App'x 161 (Third Circuit, 2017)
Frank Dippolito v. United States
704 F. App'x 199 (Third Circuit, 2017)
Brownback v. King
592 U.S. 209 (Supreme Court, 2021)
Natale v. Camden County Correctional Facility
318 F.3d 575 (Third Circuit, 2003)
Dupont v. United States
197 F. Supp. 3d 678 (D. New Jersey, 2016)